103 related articles for article (PubMed ID: 31411851)
1. Development of a Cyclic Peptide Inhibitor of the p6/UEV Protein-Protein Interaction.
Lennard KR; Gardner RM; Doigneaux C; Castillo F; Tavassoli A
ACS Chem Biol; 2019 Sep; 14(9):1874-1878. PubMed ID: 31411851
[TBL] [Abstract][Full Text] [Related]
2. Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.
Anang S; Kaushik N; Hingane S; Kumari A; Gupta J; Asthana S; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068652
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
[TBL] [Abstract][Full Text] [Related]
4. RNA Binding Suppresses Tsg101 Recognition of Ub-Modified Gag and Facilitates Recruitment to the Plasma Membrane.
Watanabe SM; Strickland M; Tjandra N; Carter CA
Viruses; 2020 Apr; 12(4):. PubMed ID: 32326417
[TBL] [Abstract][Full Text] [Related]
5. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors.
Strickland M; Ehrlich LS; Watanabe S; Khan M; Strub MP; Luan CH; Powell MD; Leis J; Tjandra N; Carter CA
Nat Commun; 2017 Nov; 8(1):1391. PubMed ID: 29123089
[TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of HIV-1 egress.
Waheed AA; Freed EO
ACS Chem Biol; 2008 Dec; 3(12):745-7. PubMed ID: 19099395
[TBL] [Abstract][Full Text] [Related]
7. The NC domain of HIV-1 Gag contributes to the interaction of Gag with TSG101.
El Meshri SE; Boutant E; Mouhand A; Thomas A; Larue V; Richert L; Vivet-Boudou V; Mély Y; Tisné C; Muriaux D; de Rocquigny H
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1421-1431. PubMed ID: 29571744
[TBL] [Abstract][Full Text] [Related]
8. A lanthipeptide library used to identify a protein-protein interaction inhibitor.
Yang X; Lennard KR; He C; Walker MC; Ball AT; Doigneaux C; Tavassoli A; van der Donk WA
Nat Chem Biol; 2018 Apr; 14(4):375-380. PubMed ID: 29507389
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.
Pornillos O; Alam SL; Davis DR; Sundquist WI
Nat Struct Biol; 2002 Nov; 9(11):812-7. PubMed ID: 12379843
[TBL] [Abstract][Full Text] [Related]
10. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO
J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
[TBL] [Abstract][Full Text] [Related]
12. Novel Tsg101 Binding Partners Regulate Viral L Domain Trafficking.
Strickland M; Nyenhuis D; Watanabe SM; Tjandra N; Carter CA
Viruses; 2021 Jun; 13(6):. PubMed ID: 34203832
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction.
Im YJ; Kuo L; Ren X; Burgos PV; Zhao XZ; Liu F; Burke TR; Bonifacino JS; Freed EO; Hurley JH
Structure; 2010 Nov; 18(11):1536-47. PubMed ID: 21070952
[TBL] [Abstract][Full Text] [Related]
14. [The action of TSG101 on HIV-1 budding and related inhibitors].
Chen HF; Liu XY
Yao Xue Xue Bao; 2008 Dec; 43(12):1165-70. PubMed ID: 19244744
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
Demirov DG; Ono A; Orenstein JM; Freed EO
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
[TBL] [Abstract][Full Text] [Related]
16. Identification of human immunodeficiency virus type-1 Gag-TSG101 interaction inhibitors by high-throughput screening.
Siarot L; Chutiwitoonchai N; Sato H; Chang H; Sato H; Fujino M; Murakami T; Aono T; Kodama E; Kuroda K; Takei M; Aida Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2970-2976. PubMed ID: 30126636
[TBL] [Abstract][Full Text] [Related]
17. Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag.
Friedrich M; Setz C; Hahn F; Matthaei A; Fraedrich K; Rauch P; Henklein P; Traxdorf M; Fossen T; Schubert U
Viruses; 2016 Apr; 8(4):117. PubMed ID: 27120610
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich domain of human ALIX contains multiple TSG101-UEV interaction sites and forms phosphorylation-mediated reversible amyloids.
Elias RD; Ma W; Ghirlando R; Schwieters CD; Reddy VS; Deshmukh L
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24274-24284. PubMed ID: 32917811
[TBL] [Abstract][Full Text] [Related]
19. PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C.
Sharma S; Arunachalam PS; Menon M; Ragupathy V; Satya RV; Jebaraj J; Aralaguppe SG; Rao C; Pal S; Saravanan S; Murugavel KG; Balakrishnan P; Solomon S; Hewlett I; Ranga U
J Biol Chem; 2018 Jul; 293(30):11687-11708. PubMed ID: 29773649
[TBL] [Abstract][Full Text] [Related]
20. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein.
Pornillos O; Higginson DS; Stray KM; Fisher RD; Garrus JE; Payne M; He GP; Wang HE; Morham SG; Sundquist WI
J Cell Biol; 2003 Aug; 162(3):425-34. PubMed ID: 12900394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
